Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 222

1.

Ustekinumab Serum Trough Levels May Identify Suboptimal Responders to Ustekinumab in Crohn's Disease.

Painchart C, Brabant S, Duveau N, Nachury M, Desreumaux P, Branche J, Gérard R, Prevost CLD, Wils P, Lambin T, Boualit M, Labalette M, Pariente B.

Dig Dis Sci. 2019 Oct 10. doi: 10.1007/s10620-019-05865-3. [Epub ahead of print]

PMID:
31599389
2.

Contribution of the Gut Microbiota in P28GST-Mediated Anti-Inflammatory Effects: Experimental and Clinical Insights.

Foligné B, Plé C, Titécat M, Dendooven A, Pagny A, Daniel C, Singer E, Pottier M, Bertin B, Neut C, Deplanque D, Dubuquoy L, Desreumaux P, Capron M, Standaert A.

Cells. 2019 Jun 12;8(6). pii: E577. doi: 10.3390/cells8060577.

3.

IL-7 receptor influences anti-TNF responsiveness and T cell gut homing in inflammatory bowel disease.

Belarif L, Danger R, Kermarrec L, Nerrière-Daguin V, Pengam S, Durand T, Mary C, Kerdreux E, Gauttier V, Kucik A, Thepenier V, Martin JC, Chang C, Rahman A, Guen NS, Braudeau C, Abidi A, David G, Malard F, Takoudju C, Martinet B, Gérard N, Neveu I, Neunlist M, Coron E, MacDonald TT, Desreumaux P, Mai HL, Le Bas-Bernardet S, Mosnier JF, Merad M, Josien R, Brouard S, Soulillou JP, Blancho G, Bourreille A, Naveilhan P, Vanhove B, Poirier N.

J Clin Invest. 2019 Apr 2;129(5):1910-1925. doi: 10.1172/JCI121668. eCollection 2019 Apr 2.

4.

Vedolizumab has no efficacy on articular manifestations in patients with spondyloarthritis associated with inflammatory bowel disease.

Paccou J, Nachury M, Duchemin C, Desreumaux P, Flipo RM, Pariente B.

Joint Bone Spine. 2019 Oct;86(5):654-656. doi: 10.1016/j.jbspin.2019.01.008. Epub 2019 Jan 31. No abstract available.

PMID:
30711690
5.

Treatment with P28GST, a schistosome-derived enzyme, after acute colitis induction in mice: Decrease of intestinal inflammation associated with a down regulation of Th1/Th17 responses.

Sarazin A, Dendooven A, Delbeke M, Gatault S, Pagny A, Standaert A, Rousseaux C, Desreumaux P, Dubuquoy L, Capron M.

PLoS One. 2018 Dec 28;13(12):e0209681. doi: 10.1371/journal.pone.0209681. eCollection 2018.

6.

The RAGE signaling pathway is involved in intestinal inflammation and represents a promising therapeutic target for Inflammatory Bowel Diseases.

Body-Malapel M, Djouina M, Waxin C, Langlois A, Gower-Rousseau C, Zerbib P, Schmidt AM, Desreumaux P, Boulanger E, Vignal C.

Mucosal Immunol. 2019 Mar;12(2):468-478. doi: 10.1038/s41385-018-0119-z. Epub 2018 Dec 12.

PMID:
30542111
7.

Aluminum Ingestion Promotes Colorectal Hypersensitivity in Rodents.

Esquerre N, Basso L, Dubuquoy C, Djouina M, Chappard D, Blanpied C, Desreumaux P, Vergnolle N, Vignal C, Body-Malapel M.

Cell Mol Gastroenterol Hepatol. 2018 Sep 20;7(1):185-196. doi: 10.1016/j.jcmgh.2018.09.012. eCollection 2019.

8.

Oral vancomycin induces sustained deep remission in adult patients with ulcerative colitis and primary sclerosing cholangitis.

de Chambrun GP, Nachury M, Funakoshi N, Gerard R, Bismuth M, Valats JC, Panaro F, Navarro F, Desreumaux P, Pariente B, Blanc P.

Eur J Gastroenterol Hepatol. 2018 Oct;30(10):1247-1252. doi: 10.1097/MEG.0000000000001223.

PMID:
30052539
9.

Treatments for Crohn's Disease-Associated Bowel Damage: A Systematic Review.

Pariente B, Hu S, Bettenworth D, Speca S, Desreumaux P, Meuwis MA, Danese S, Rieder F, Louis E.

Clin Gastroenterol Hepatol. 2019 Apr;17(5):847-856. doi: 10.1016/j.cgh.2018.06.043. Epub 2018 Aug 23. Review.

PMID:
30012430
10.

High carriage of adherent invasive E. coli in wildlife and healthy individuals.

Rahmouni O, Vignal C, Titécat M, Foligné B, Pariente B, Dubuquoy L, Desreumaux P, Neut C.

Gut Pathog. 2018 Jun 14;10:23. doi: 10.1186/s13099-018-0248-7. eCollection 2018.

11.

Neoboutonia melleri var velutina Prain: in vitro and in vivo hepatoprotective effects of the aqueous stem bark extract on acute hepatitis models.

Endougou Effa AM, Gantier E, Hennebelle T, Roumy V, Rivière C, Dimo T, Kamtchouing P, Desreumaux P, Dubuquoy L.

BMC Complement Altern Med. 2018 Jan 22;18(1):24. doi: 10.1186/s12906-018-2091-2.

12.

Randomised trial and open-label extension study of an anti-interleukin-6 antibody in Crohn's disease (ANDANTE I and II).

Danese S, Vermeire S, Hellstern P, Panaccione R, Rogler G, Fraser G, Kohn A, Desreumaux P, Leong RW, Comer GM, Cataldi F, Banerjee A, Maguire MK, Li C, Rath N, Beebe J, Schreiber S.

Gut. 2019 Jan;68(1):40-48. doi: 10.1136/gutjnl-2017-314562. Epub 2017 Dec 15.

13.

Effects of urban coarse particles inhalation on oxidative and inflammatory parameters in the mouse lung and colon.

Vignal C, Pichavant M, Alleman LY, Djouina M, Dingreville F, Perdrix E, Waxin C, Ouali Alami A, Gower-Rousseau C, Desreumaux P, Body-Malapel M.

Part Fibre Toxicol. 2017 Nov 22;14(1):46. doi: 10.1186/s12989-017-0227-z.

14.

Effect of PF-00547659 on Central Nervous System Immune Surveillance and Circulating β7+ T Cells in Crohn's Disease: Report of the TOSCA Study.

D'Haens G, Vermeire S, Vogelsang H, Allez M, Desreumaux P, Van Gossum A, Sandborn WJ, Baumgart DC, Ransohoff RM, Comer GM, Ahmad A, Cataldi F, Cheng J, Clare R, Gorelick KJ, Kaminski A, Pradhan V, Rivers S, Sikpi MO, Zhang Y, Hassan-Zahraee M, Reinisch W, Stuve O.

J Crohns Colitis. 2018 Jan 24;12(2):188-196. doi: 10.1093/ecco-jcc/jjx128.

15.

Peroxisome proliferator-activated receptor gamma (PPARγ) regulates lactase expression and activity in the gut.

Fumery M, Speca S, Langlois A, Davila AM, Dubuquoy C, Grauso M, Martin Mena A, Figeac M, Metzger D, Rousseaux C, Colombel JF, Dubuquoy L, Desreumaux P, Bertin B.

EMBO Mol Med. 2017 Nov;9(11):1471-1481. doi: 10.15252/emmm.201707795.

16.

The Expression of the Short Isoform of Thymic Stromal Lymphopoietin in the Colon Is Regulated by the Nuclear Receptor Peroxisome Proliferator Activated Receptor-Gamma and Is Impaired during Ulcerative Colitis.

Martin Mena A, Langlois A, Speca S, Schneider L, Desreumaux P, Dubuquoy L, Bertin B.

Front Immunol. 2017 Sep 4;8:1052. doi: 10.3389/fimmu.2017.01052. eCollection 2017.

17.

Patients with Crohn's Disease with High Body Mass Index Present More Frequent and Rapid Loss of Response to Infliximab.

Guerbau L, Gerard R, Duveau N, Staumont-Sallé D, Branche J, Maunoury V, Cattan S, Wils P, Boualit M, Libier L, Cotteau-Leroy A, Desreumaux P, Nachury M, Pariente B.

Inflamm Bowel Dis. 2017 Oct;23(10):1853-1859. doi: 10.1097/MIB.0000000000001179.

PMID:
28837519
18.

Dramatic Increase in Incidence of Ulcerative Colitis and Crohn's Disease (1988-2011): A Population-Based Study of French Adolescents.

Ghione S, Sarter H, Fumery M, Armengol-Debeir L, Savoye G, Ley D, Spyckerelle C, Pariente B, Peyrin-Biroulet L, Turck D, Gower-Rousseau C, Andre JM, Antonietti M, Aouakli A, Armand A, Aroichane I, Assi F, Aubet JP, Auxenfants E, Ayafi-Ramelot F, Bankovski D, Barbry B, Bardoux N, Baron P, Baudet A, Bazin B, Bebahani A, Becqwort JP, Benet V, Benali H, Benguigui C, Soussan BE, Bental A, Berkelmans I, Bernet J, Bernou K, Bernou-Dron C, Bertot P, Bertiaux-Vandaële N, Bertrand V, Billoud E, Biron N, Bismuth B, Bleuet M, Blondel F, Blondin V, Bohon P, Boniface E, Bonnière P, Bonvarlet E, Bonvarlet P, Boruchowicz A, Bostvironnois R, Boualit M, Bouche B, Boudaillez C, Bourgeaux C, Bourgeois M, Bourguet A, Bourienne A, Branche J, Bray G, Brazier F, Breban P, Brihier H, Brung-Lefebvre V, Bulois P, Burgiere P, Butel J, Canva JY, Canva-Delcambre V, Capron JP, Cardot F, Carpentier P, Cartier E, Cassar JF, Cassagnou M, Castex JF, Catala P, Cattan S, Catteau S, Caujolle B, Cayron G, Chandelier C, Chantre M, Charles J, Charneau T, Chavance-Thelu M, Chirita D, Choteau A, Claerbout JF, Clergue PY, Coevoet H, Cohen G, Collet R, Colombel JF, Coopman S, Corvisart J, Cortot A, Couttenier F, Crinquette JF, Crombe V, Dadamessi I, Dapvril V, Davion T, Dautreme S, Debas J, Degrave N, Dehont F, Delatre C, Delcenserie R, Delette O, Delgrange T, Delhoustal L, Delmotte JS, Demmane S, Deregnaucourt G, Descombes P, Desechalliers JP, Desmet P, Desreumaux P, Desseaux G, Desurmont P, Devienne A, Devouge E, Devred M, Devroux A, Dewailly A, Dharancy S, Di Fiore A, Djeddi D, Djedir R, Dreher-Duwat ML, Dubois R, Dubuque C, Ducatillon P, Duclay J, Ducrocq B, Ducrot F, Ducrotte P, Dufilho A, Duhamel C, Dujardin D, Dumant-Forest C, Dupas JL, Dupont F, Duranton Y, Duriez A, El Achkar K, El Farisi M, Elie C, Elie-Legrand MC, Elkhaki A, Eoche M, Evrard D, Evrard JP, Fatome A, Filoche B, Finet L, Flahaut M, Flamme C, Foissey D, Fournier P, Foutrein-Comes MC, Foutrein P, Fremond D, Frere T, Fumery M, Gallet P, Gamblin C, Ganga-Zandzou PS, Gérard R, Geslin G, Gheyssens Y, Ghossini N, Ghrib S, Gilbert T, Gillet B, Godard D, Godard P, Godchaux JM, Godchaux R, Goegebeur G, Goria O, Gottrand F, Gower P, Grandmaison B, Groux M, Guedon C, Guillard JF, Guillem L, Guillemot F, Guimber D, Haddouche B, Hakim S, Hanon D, Hautefeuille V, Heckestweiller P, Hecquet G, Hedde JP, Hellal H, Henneresse PE, Heyman B, Heraud M, Herve S, Hochain P, Houssin-Bailly L, Houcke P, Huguenin B, Iobagiu S, Ivanovic A, Iwanicki-Caron I, Janicki E, Jarry M, Jeu J, Joly JP, Jonas C, Katherin F, Kerleveo A, Khachfe A, Kiriakos A, Kiriakos J, Klein O, Kohut M, Kornhauser R, Koutsomanis D, Laberenne JE, Laffineur G, Lagarde M, Lannoy P, Lapchin J, Lapprand M, Laude D, Leblanc R, Lecieux P, Leclerc N, Le Couteulx C, Ledent J, Lefebvre J, Lefiliatre P, Legrand C, Le Grix A, Lelong P, Leluyer B, Lenaerts C, Lepileur L, Leplat A, Lepoutre-Dujardin E, Leroi H, Leroy MY, Lesage JP, Lesage X, Lesage J, Lescanne-Darchis I, Lescut J, Lescut D, Leurent B, Levy P, Lhermie M, Lion A, Lisambert B, Loire F, Louf S, Louvet A, Luciani M, Lucidarme D, Lugand J, Macaigne O, Maetz D, Maillard D, Mancheron H, Manolache O, Marks-Brunel AB, Marti R, Martin F, Martin G, Marzloff E, Mathurin P, Mauillon J, Maunoury V, Maupas JL, Mesnard B, Metayer P, Methari L, Meurisse B, Meurisse F, Michaud L, Mirmaran X, Modaine P, Monthe A, Morel L, Mortier PE, Moulin E, Mouterde O, Mudry J, Nachury M, Khac NE, Notteghem B, Ollevier V, Ostyn A, Ouraghi A, Ouvry D, Paillot B, Panien-Claudot N, Paoletti C, Papazian A, Parent B, Pariente B, Paris JC, Patrier P, Paupart L, Pauwels B, Pauwels M, Petit R, Piat M, Piotte S, Plane C, Plouvier B, Pollet E, Pommelet P, Pop D, Pordes C, Pouchain G, Prades P, Prevost A, Prevost JC, Quesnel B, Queuniet AM, Quinton JF, Rabache A, Rabelle P, Raclot G, Ratajczyk S, Rault D, Razemon V, Reix N, Revillon M, Richez C, Robinson P, Rodriguez J, Roger J, Roux JM, Rudelli A, Saber A, Savoye G, Schlosseberg P, Segrestin M, Seguy D, Serin M, Seryer A, Sevenet F, Shekh N, Silvie J, Simon V, Spyckerelle C, Talbodec N, Techy A, Thelu JL, Thevenin A, Thiebault H, Thomas J, Thorel JM, Tielman G, Tode M, Toisin J, Tonnel J, Touchais JY, Touze Y, Tranvouez JL, Triplet C, Turck D, Uhlen S, Vaillant E, Valmage C, Vanco D, Vandamme H, Vanderbecq E, Eecken VE, Vandermolen P, Vandevenne P, Vandeville L, Vandewalle A, Vandewalle C, Vaneslander P, Vanhoove JP, Vanrenterghem A, Varlet P, Vasies I, Verbiese G, Vernier-Massouille G, Vermelle P, Verne C, Vezilier-Cocq P, Vigneron B, Vincendet M, Viot J, Voiment YM, Wacrenier A, Waeghemaecker L, Wallez JY, Wantiez M, Wartel F, Weber J, Willocquet JL, Wizla N, Wolschies E, Zalar A, Zaouri B, Zellweger A, Ziade C; Epimad Group.

Am J Gastroenterol. 2018 Feb;113(2):265-272. doi: 10.1038/ajg.2017.228. Epub 2017 Aug 15.

PMID:
28809388
19.

Role of glycogen synthase kinase-3β and PPAR-γ on epithelial-to-mesenchymal transition in DSS-induced colorectal fibrosis.

Di Gregorio J, Sferra R, Speca S, Vetuschi A, Dubuquoy C, Desreumaux P, Pompili S, Cristiano L, Gaudio E, Flati V, Latella G.

PLoS One. 2017 Feb 16;12(2):e0171093. doi: 10.1371/journal.pone.0171093. eCollection 2017.

20.

Bacteriophages Targeting Adherent Invasive Escherichia coli Strains as a Promising New Treatment for Crohn's Disease.

Galtier M, De Sordi L, Sivignon A, de Vallée A, Maura D, Neut C, Rahmouni O, Wannerberger K, Darfeuille-Michaud A, Desreumaux P, Barnich N, Debarbieux L.

J Crohns Colitis. 2017 Jul 1;11(7):840-847. doi: 10.1093/ecco-jcc/jjw224.

21.

Saccharomyces cerevisiae CNCM I-3856 in irritable bowel syndrome: An individual subject meta-analysis.

Cayzeele-Decherf A, Pélerin F, Leuillet S, Douillard B, Housez B, Cazaubiel M, Jacobson GK, Jüsten P, Desreumaux P.

World J Gastroenterol. 2017 Jan 14;23(2):336-344. doi: 10.3748/wjg.v23.i2.336.

22.

[Enteric microflora in inflammatory bowel disease patients].

Rahmouni O, Dubuquoy L, Desreumaux P, Neut C.

Med Sci (Paris). 2016 Nov;32(11):968-973. doi: 10.1051/medsci/20163211012. Epub 2016 Dec 23. Review. French.

23.

Ustekinumab as Induction and Maintenance Therapy for Crohn's Disease.

Feagan BG, Sandborn WJ, Gasink C, Jacobstein D, Lang Y, Friedman JR, Blank MA, Johanns J, Gao LL, Miao Y, Adedokun OJ, Sands BE, Hanauer SB, Vermeire S, Targan S, Ghosh S, de Villiers WJ, Colombel JF, Tulassay Z, Seidler U, Salzberg BA, Desreumaux P, Lee SD, Loftus EV Jr, Dieleman LA, Katz S, Rutgeerts P; UNITI–IM-UNITI Study Group.

N Engl J Med. 2016 Nov 17;375(20):1946-1960.

24.

Adalimumab dose escalation is effective and well tolerated in Crohn's disease patients with secondary loss of response to adalimumab.

Duveau N, Nachury M, Gerard R, Branche J, Maunoury V, Boualit M, Wils P, Desreumaux P, Pariente B.

Dig Liver Dis. 2017 Feb;49(2):163-169. doi: 10.1016/j.dld.2016.11.002. Epub 2016 Nov 14.

PMID:
27899263
25.

Previous Exposure to Multiple Anti-TNF Is Associated with Decreased Efficiency in Preventing Postoperative Crohn's Disease Recurrence.

Collins M, Sarter H, Gower-Rousseau C, Koriche D, Libier L, Nachury M, Cortot A, Zerbib P, Blanc P, Desreumaux P, Colombel JF, Peyrin-Biroulet L, Pineton de Chambrun G.

J Crohns Colitis. 2017 Mar 1;11(3):281-288. doi: 10.1093/ecco-jcc/jjw151.

PMID:
27578800
26.

Ileal or Anastomotic Location of Lesions Does Not Impact Rate of Postoperative Recurrence in Crohn's Disease Patients Classified i2 on the Rutgeerts Score.

Bayart P, Duveau N, Nachury M, Zerbib P, Gerard R, Branche J, Maunoury V, Wils P, Boruchowicz A, Boualit M, Laberenne JE, Manolache O, Desreumaux P, de Chambrun GP, Pariente B.

Dig Dis Sci. 2016 Oct;61(10):2986-2992. doi: 10.1007/s10620-016-4215-1. Epub 2016 Jul 11.

PMID:
27401274
27.

Probiotic Yeast Therapy for Irritable Bowel Syndrome.

Pélerin F, Desreumaux P.

J Neurogastroenterol Motil. 2016 Jul 30;22(3):542. doi: 10.5056/jnm16075. No abstract available.

28.

Toxicological consequences of experimental exposure to aluminum in human intestinal epithelial cells.

Djouina M, Esquerre N, Desreumaux P, Vignal C, Body-Malapel M.

Food Chem Toxicol. 2016 May;91:108-16. doi: 10.1016/j.fct.2016.03.008. Epub 2016 Mar 17.

PMID:
26995227
29.

Gut: An underestimated target organ for Aluminum.

Vignal C, Desreumaux P, Body-Malapel M.

Morphologie. 2016 Jun;100(329):75-84. doi: 10.1016/j.morpho.2016.01.003. Epub 2016 Mar 9. Review.

PMID:
26970682
30.

Novel PPARγ Modulator GED-0507-34 Levo Ameliorates Inflammation-driven Intestinal Fibrosis.

Speca S, Rousseaux C, Dubuquoy C, Rieder F, Vetuschi A, Sferra R, Giusti I, Bertin B, Dubuquoy L, Gaudio E, Desreumaux P, Latella G.

Inflamm Bowel Dis. 2016 Feb;22(2):279-92. doi: 10.1097/MIB.0000000000000618.

31.

The schistosome glutathione S-transferase P28GST, a unique helminth protein, prevents intestinal inflammation in experimental colitis through a Th2-type response with mucosal eosinophils.

Driss V, El Nady M, Delbeke M, Rousseaux C, Dubuquoy C, Sarazin A, Gatault S, Dendooven A, Riveau G, Colombel JF, Desreumaux P, Dubuquoy L, Capron M.

Mucosal Immunol. 2016 Mar;9(2):322-35. doi: 10.1038/mi.2015.62. Epub 2015 Jul 15.

32.

Acrylamide induces accelerated endothelial aging in a human cell model.

Sellier C, Boulanger E, Maladry F, Tessier FJ, Lorenzi R, Nevière R, Desreumaux P, Beuscart JB, Puisieux F, Grossin N.

Food Chem Toxicol. 2015 Sep;83:140-5. doi: 10.1016/j.fct.2015.05.021. Epub 2015 Jun 10.

PMID:
26070502
33.

Delivery of a mucin domain enriched in cysteine residues strengthens the intestinal mucous barrier.

Gouyer V, Dubuquoy L, Robbe-Masselot C, Neut C, Singer E, Plet S, Geboes K, Desreumaux P, Gottrand F, Desseyn JL.

Sci Rep. 2015 May 14;5:9577. doi: 10.1038/srep09577.

34.

Eosinophilic enteritis.

Pineton de Chambrun G, Desreumaux P, Cortot A.

Dig Dis. 2015;33(2):183-9. doi: 10.1159/000369540. Epub 2015 Apr 22. Review.

PMID:
25925921
35.

Superantigenic Yersinia pseudotuberculosis induces the expression of granzymes and perforin by CD4+ T cells.

Goubard A, Loïez C, Abe J, Fichel C, Herwegh S, Faveeuw C, Porte R, Cayet D, Sebbane F, Penet S, Foligné B, Desreumaux P, Saito H, Sirard JC, Simonet M, Carnoy C.

Infect Immun. 2015 May;83(5):2053-64. doi: 10.1128/IAI.02339-14. Epub 2015 Mar 9.

36.
37.

Conformational Restriction Leading to a Selective CB2 Cannabinoid Receptor Agonist Orally Active Against Colitis.

El Bakali J, Muccioli GG, Body-Malapel M, Djouina M, Klupsch F, Ghinet A, Barczyk A, Renault N, Chavatte P, Desreumaux P, Lambert DM, Millet R.

ACS Med Chem Lett. 2014 Dec 4;6(2):198-203. doi: 10.1021/ml500439x. eCollection 2015 Feb 12.

38.

The role of PPARγ-mediated signalling in skin biology and pathology: new targets and opportunities for clinical dermatology.

Ramot Y, Mastrofrancesco A, Camera E, Desreumaux P, Paus R, Picardo M.

Exp Dermatol. 2015 Apr;24(4):245-51. doi: 10.1111/exd.12647. Review.

PMID:
25644500
39.

Intestinal steroidogenesis.

Bouguen G, Dubuquoy L, Desreumaux P, Brunner T, Bertin B.

Steroids. 2015 Nov;103:64-71. doi: 10.1016/j.steroids.2014.12.022. Epub 2015 Jan 2. Review.

PMID:
25560486
40.

A randomized clinical trial of Saccharomyces cerevisiae versus placebo in the irritable bowel syndrome.

Pineton de Chambrun G, Neut C, Chau A, Cazaubiel M, Pelerin F, Justen P, Desreumaux P.

Dig Liver Dis. 2015 Feb;47(2):119-24. doi: 10.1016/j.dld.2014.11.007. Epub 2014 Nov 13.

41.

In vivo efficacy of microbiota-sensitive coatings for colon targeting: a promising tool for IBD therapy.

Karrout Y, Dubuquoy L, Piveteau C, Siepmann F, Moussa E, Wils D, Beghyn T, Neut C, Flament MP, Guerin-Deremaux L, Dubreuil L, Deprez B, Desreumaux P, Siepmann J.

J Control Release. 2015 Jan 10;197:121-30. doi: 10.1016/j.jconrel.2014.11.006. Epub 2014 Nov 10.

PMID:
25445696
42.

Peroxisome proliferator-activated receptor gamma in the colon: inflammation and innate antimicrobial immunity.

Speca S, Dubuquoy L, Desreumaux P.

J Clin Gastroenterol. 2014 Nov-Dec;48 Suppl 1:S23-7. doi: 10.1097/MCG.0000000000000253. Review.

PMID:
25291120
43.

Intestinal steroidogenesis controls PPARγ expression in the colon and is impaired during ulcerative colitis.

Bouguen G, Langlois A, Djouina M, Branche J, Koriche D, Dewaeles E, Mongy A, Auwerx J, Colombel JF, Desreumaux P, Dubuquoy L, Bertin B.

Gut. 2015 Jun;64(6):901-10. doi: 10.1136/gutjnl-2014-307618. Epub 2014 Jul 22.

44.

[Autologous stem cell transplantation for autoimmune diseases: recommendations from the SFGM-TC].

Farge D, Terriou L, Badoglio M, Cras A, Desreumaux P, Hadj-Khelifa S, Marjanovic Z, Moisan A, Dulery R, Faucher C, Hij A, Martin T, Vermersch P, Yakoub-Agha I; SFGM-TC.

Pathol Biol (Paris). 2014 Aug;62(4):204-8. doi: 10.1016/j.patbio.2014.05.012. Epub 2014 Jul 10. French.

PMID:
25017794
45.

Glugacon-like peptide-2: broad receptor expression, limited therapeutic effect on intestinal inflammation and novel role in liver regeneration.

El-Jamal N, Erdual E, Neunlist M, Koriche D, Dubuquoy C, Maggiotto F, Chevalier J, Berrebi D, Dubuquoy L, Boulanger E, Cortot A, Desreumaux P.

Am J Physiol Gastrointest Liver Physiol. 2014 Aug 1;307(3):G274-85. doi: 10.1152/ajpgi.00389.2012. Epub 2014 May 29.

46.

Therapeutical potential of CB₂ receptors in immune-related diseases.

Leleu-Chavain N, Desreumaux P, Chavatte P, Millet R.

Curr Mol Pharmacol. 2013 Nov;6(3):183-203. Review.

PMID:
24720538
47.

Switching cannabinoid response from CB(2) agonists to FAAH inhibitors.

Tourteau A, Leleu-Chavain N, Body-Malapel M, Andrzejak V, Barczyk A, Djouina M, Rigo B, Desreumaux P, Chavatte P, Millet R.

Bioorg Med Chem Lett. 2014 Mar 1;24(5):1322-6. doi: 10.1016/j.bmcl.2014.01.056. Epub 2014 Jan 28.

PMID:
24508127
48.

Switching invariant natural killer T (iNKT) cell response from anticancerous to anti-inflammatory effect: molecular bases.

Laurent X, Bertin B, Renault N, Farce A, Speca S, Milhomme O, Millet R, Desreumaux P, Hénon E, Chavatte P.

J Med Chem. 2014 Jul 10;57(13):5489-508. doi: 10.1021/jm4010863. Epub 2014 Feb 12. Review.

PMID:
24428717
49.

Preclinical studies of a specific PPARγ modulator in the control of skin inflammation.

Mastrofrancesco A, Kovacs D, Sarra M, Bastonini E, Cardinali G, Aspite N, Camera E, Chavatte P, Desreumaux P, Monteleone G, Picardo M.

J Invest Dermatol. 2014 Apr;134(4):1001-1011. doi: 10.1038/jid.2013.448. Epub 2013 Oct 28.

50.

Aluminum enhances inflammation and decreases mucosal healing in experimental colitis in mice.

Pineton de Chambrun G, Body-Malapel M, Frey-Wagner I, Djouina M, Deknuydt F, Atrott K, Esquerre N, Altare F, Neut C, Arrieta MC, Kanneganti TD, Rogler G, Colombel JF, Cortot A, Desreumaux P, Vignal C.

Mucosal Immunol. 2014 May;7(3):589-601. doi: 10.1038/mi.2013.78. Epub 2013 Oct 16.

Supplemental Content

Loading ...
Support Center